{"id":"W2946868463","doi":"10.1200/jco.2019.37.15_suppl.1034","title":"Clinical characteristics of patients with no evidence of disease (NED) versus residual disease (RES) to anti-HER2 therapy in metastatic breast cancer (MBC): A multi-institutional analysis.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Baker Hughes (Canada); University Health Network; University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Trastuzumab; Pertuzumab; Internal medicine; Taxane; Metastatic breast cancer; Trastuzumab emtansine; Breast cancer; Oncology; Regimen; Chemotherapy; Stage (stratigraphy); Cancer; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001280192,0.0002138733,0.0004482257,0.001202404,0.0002851001,0.0005216375,0.0003512093,0.0003725952,0.00106739],"category_scores_gemma":[0.001595058,0.0001833126,0.0006092103,0.001437266,0.000293098,0.0004051039,0.0005350171,0.000316904,0.0001820766],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005620811,"about_ca_system_score_gemma":0.0004417525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003096832,"about_ca_topic_score_gemma":0.004400612,"domain_scores_codex":[0.9993402,0.0001729246,0.0001078386,0.0001616866,0.0001053978,0.0001119034],"domain_scores_gemma":[0.9977818,0.000438513,0.001077771,0.0001449003,0.0001398384,0.0004170985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007813345,0.00002730409,0.9979912,0.0000112243,0.00009863546,0.00004341192,0.00002339864,0.0000584257,0.0002134148,0.000005657132,0.00007211447,0.0006739421],"study_design_scores_gemma":[0.00003099704,0.0002606691,0.9988711,0.000003170257,0.00005891619,0.0002760571,0.00008280725,0.0001478913,0.00006607577,0.000008548046,0.0001889139,0.00000481951],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986461,0.0001980329,0.00005189807,0.000009553126,0.000002071497,0.00002163463,0.0008595441,0.000003074125,0.0002081593],"genre_scores_gemma":[0.9986607,0.00004663078,0.00005552152,0.00001290606,0.000006024388,0.00002205555,0.001123816,0.000001821201,0.00007050767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003096832,"threshold_uncertainty_score":0.006770372,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07790662826635882,"score_gpt":0.4466586246627598,"score_spread":0.368751996396401,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}